These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 5423363)

  • 1. Cefazolin, a new semisynthetic cephalosporin antibiotic. 3. Absorption, excretion and tissue distribution in parenteral administration.
    Nishida M; Matsubara T; Murakawa T; Mine Y; Yokota Y; Goto S; Kuwahara S
    J Antibiot (Tokyo); 1970 Apr; 23(4):184-94. PubMed ID: 5423363
    [No Abstract]   [Full Text] [Related]  

  • 2. Cefazolin, a new semisynthetic cephalosporin antibiotic. VI. Excretion and metabolism of cefazolin- 14 C in rats after intramuscular administration.
    Kozatani J; Okui M; Matsubara T; Nishida M
    J Antibiot (Tokyo); 1972 Feb; 25(2):86-93. PubMed ID: 5034810
    [No Abstract]   [Full Text] [Related]  

  • 3. Cefazolin vs cephalothin and cephaloridine. A comparison of their clinical pharmacology.
    Regamey C; Gordon RC; Kirby WM
    Arch Intern Med; 1974 Mar; 133(3):407-10. PubMed ID: 4811478
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies on new antibiotic lividomycins. VI. Absorption, excretion and tissue distribution of lividomycin A.
    Mori T; Aoki M; Aoki Y; Shirai K; Chiba K
    J Antibiot (Tokyo); 1972 Nov; 25(11):634-40. PubMed ID: 4647833
    [No Abstract]   [Full Text] [Related]  

  • 5. Ceftezole, a new cephalosporin C derivative II. Distribution and excretion in parenteral administration.
    Harada Y; Matsubara S; Kakimoto M; Noto T; Nehashi T
    J Antibiot (Tokyo); 1976 Oct; 29(10):1071-82. PubMed ID: 994326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparative study of the distribution of semisynthetic cephalosporins in the body of rats].
    Iakovlev VP; Klimova VS; Rudzit EA
    Antibiotiki; 1979 Feb; 24(2):109-14. PubMed ID: 434800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics of biliary excretion of cefazolin and other cephalosporins with reference to the relationship between serum levels and administration conditions.
    Nishida M; Murakawa T; Matsubara T; Kohno Y; Yokota Y
    Chemotherapy; 1976; 22(1):30-6. PubMed ID: 1253628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absorption, distribution and excretion of SCE-963, a new broad-spectrum cephalosporin, in mice, rats, rabbits and dogs.
    Tsuchiya K; Kondo M; Kita Y; Noji Y; Takeuchi M; Fugono T
    J Antibiot (Tokyo); 1978 Dec; 31(12):1272-82. PubMed ID: 738967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cephaloridine versus cephalothin: relation of the kidney to blood level differences after parenteral administration.
    Tuano SB; Brodie JL; Kirby WM
    Antimicrob Agents Chemother (Bethesda); 1966; 6():101-6. PubMed ID: 5985234
    [No Abstract]   [Full Text] [Related]  

  • 10. Studies on chemotherapy during the perinatal period with special reference to such derivatives of cephalosporin C as cefazolin, cephaloridine and cephalothin.
    Fukada M
    Jpn J Antibiot; 1973 Jun; 26(3):197-214. PubMed ID: 4542543
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies on the pharmacokinetics of cefoxitin, cefuroxime, cephaloridine and cephalothin using subcutaneous tissue cages.
    Rylander M; Holm SE; Norrby R; Brorson JE
    Scand J Infect Dis Suppl; 1978; (13):52-7. PubMed ID: 278147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparative study of the interaction of cephalosporins with blood serum proteins and organ homogenates].
    Klimova VS; Iakovlev VP
    Antibiotiki; 1979 Nov; 24(11):835-8. PubMed ID: 507778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absorption, tissue concentration, and organ distribution of cefazolin.
    Ishiyama S; Nakayama I; Iwamoto H; Iwai S; Okui M
    Antimicrob Agents Chemother (Bethesda); 1970; 10():476-80. PubMed ID: 5521371
    [No Abstract]   [Full Text] [Related]  

  • 14. [Cephazolin: pharmacology compared with that of 2 other cephalosporins].
    Guibert J; Lavarde M; Goldstein F
    Nouv Presse Med; 1974 Apr; 3(0):19-20. PubMed ID: 4837110
    [No Abstract]   [Full Text] [Related]  

  • 15. [Absorption and excretion of cephapirin (author's transl)].
    Morikawa A; Maruta H; Mizuno D
    Jpn J Antibiot; 1974 Apr; 27(2):182-4. PubMed ID: 4546584
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacokinetics of cephalosporin antibiotics: protein-binding considerations.
    Singhvi SM; Heald AF; Schreiber EC
    Chemotherapy; 1978; 24(3):121-33. PubMed ID: 657874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on the metabolism of cephalosporins. I. The distribution and degradation of 7-[(1-14C)-3-chlorophenyl-acetamido]-cephalosporanic acid.
    Okui M; Hattori K; Nishida M
    J Antibiot (Tokyo); 1967 Sep; 20(5):287-92. PubMed ID: 5630772
    [No Abstract]   [Full Text] [Related]  

  • 18. [Blood distribution, renal and biliary excretion of a new caphalosporin, cephacetrile (Ciba 36278 Ba)].
    Brogard JM; Kuntzmann F; Lavillaureix J
    Schweiz Med Wochenschr; 1973 Jan; 103(3):110-4. PubMed ID: 4566986
    [No Abstract]   [Full Text] [Related]  

  • 19. Cefoperazone: absorption, excretion, distribution, and metabolism.
    Shimizu K
    Clin Ther; 1980; 3(Spec Issue):60-79. PubMed ID: 6446400
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacokinetics of parenteral sodium cephalexin in comparison with cephalothin and cefazolin.
    Regamey C; Libke RD; Clarke JT; Kirby WM
    Infection; 1974; 2(3):132-6. PubMed ID: 4415038
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 20.